Advertisement
Androgen deprivation therapy for prostate cancer might dramatically increase a man's risk of developing Alzheimer's disease

ADT for Prostate CA Tied to Increased Alzheimer’s Risk

0
Research suggests dose-dependent effect
The combination of effective transmission of knowledge

Med Ed Can Be Improved for High-Value, Cost-Conscious Care

0
Review shows knowledge transmission, reflective practice, supportive environment aid learning
Fewer American families are struggling to pay medical bills

CDC: Fewer Americans Struggling With Medical Bills

0
U.S. report shows 12 million are no longer in families having trouble paying for health care
Vonvendi has been approved by the U.S. Food and Drug Administration to treat adults with von Willebrand disease.

FDA Approves Vonvendi to Treat von Willebrand Disease

0
Approved for the as-needed treatment and control of bleeding episodes in adults
Consensus guidelines have been developed for clinical management of hematologic malignancies during the perinatal period

Guidelines Developed for Perinatal Hematologic Cancers

0
Diagnostic procedures, chemotherapy and radiotherapy, maternal supportive care discussed
The prices of cancer drugs vary greatly across high-income countries

Variation in Prices of Cancer Drugs in High-Income Countries

0
Difference in drug price between highest-, lowest-priced countries varies between 28 and 388 percent
For children with lactic acidosis due to severe anemia

ASH: Longer Red Blood Cell Unit Storage Noninferior

0
Longer-storage RBC units non-inferior for children with lactic acidosis due to anemia
For patients with previously untreated chronic lymphocytic leukemia or small lymphocytic lymphoma

ASH: Ibrutinib Bests Chlorambucil in Chronic Lymphocytic Leukemia

0
Improvements in progression-free survival, overall survival, response rate for ibrutinib
Researchers are zeroing in on factors that may increase the risk of leukemia after breast cancer treatment

Etiology of Leukemia in Breast Cancer Survivors Explored

0
Family history of cancer, inherited gene mutation seem to raise chances of secondary malignancy
For patients with head and neck squamous cell carcinoma

Time to Tx Initiation Impacts Survival in Head, Neck Cancer

0
Lower overall survival for time to treatment initiation of more than 46 to 52 days